Shares of SeaStar Medical Holding Co. (NASDAQ:ICU – Get Rating) traded down 1.7% during mid-day trading on Tuesday . The company traded as low as $0.59 and last traded at $0.61. 350,553 shares were traded during trading, a decline of 29% from the average session volume of 494,263 shares. The stock had previously closed at $0.62.
Analyst Ratings Changes
Separately, Maxim Group assumed coverage on shares of SeaStar Medical in a report on Thursday, April 20th. They set a “buy” rating and a $5.00 target price on the stock.
SeaStar Medical Price Performance
The firm’s fifty day moving average price is $1.77 and its two-hundred day moving average price is $3.34.
Institutional Inflows and Outflows
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
- Get a free copy of the StockNews.com research report on SeaStar Medical (ICU)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.